Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 361 citing articles:

Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth Williamson, Alex J Walker, Krishnan Bhaskaran, et al.
Nature (2020) Vol. 584, Iss. 7821, pp. 430-436
Open Access | Times Cited: 5954
Association of the COVID‐19 lockdown with smoking, drinking and attempts to quit in England: an analysis of 2019–20 data
Sarah E. Jackson, Claire Garnett, Lion Shahab, et al.
Addiction (2020) Vol. 116, Iss. 5, pp. 1233-1244
Open Access | Times Cited: 265
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic
Helen Ward, Christina Atchison, Matthew Whitaker, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 209
Ethnic disparities in hospitalisation for COVID-19 in England: The role of socioeconomic factors, mental health, and inflammatory and pro-inflammatory factors in a community-based cohort study
Camille Lassale, Bamba Gaye, Mark Hamer, et al.
Brain Behavior and Immunity (2020) Vol. 88, pp. 44-49
Open Access | Times Cited: 200
Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform
Krishnan Bhaskaran, Seb Bacon, Stephen Evans, et al.
The Lancet Regional Health - Europe (2021) Vol. 6, pp. 100109-100109
Open Access | Times Cited: 185
Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort
Ashley K. Clift, Adam Von Ende, Pui San Tan, et al.
Thorax (2021) Vol. 77, Iss. 1, pp. 65-73
Open Access | Times Cited: 166
Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)
Edina Cenko, Lina Badimón, Raffaele Bugiardini, et al.
Cardiovascular Research (2021) Vol. 117, Iss. 14, pp. 2705-2729
Open Access | Times Cited: 127
Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis
Roengrudee Patanavanich, Stanton A. Glantz
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 121
COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors
Joshua Elliott, Barbara Bodinier, Matthew Whitaker, et al.
European Journal of Epidemiology (2021) Vol. 36, Iss. 3, pp. 299-309
Open Access | Times Cited: 114
Impact of COVID-19 lockdown on smoking consumption in a large representative sample of Italian adults
Giulia Carreras, Alessandra Lugo, Chiara Stival, et al.
Tobacco Control (2021) Vol. 31, Iss. 5, pp. 615-622
Closed Access | Times Cited: 113
Smoking and risk of negative outcomes among COVID-19 patients: A systematic review and meta-analysis
Adinat Umnuaypornlert, Sukrit Kanchanasurakit, Don Eliseo Lucero‐Prisno, et al.
Tobacco Induced Diseases (2021) Vol. 19, Iss. February, pp. 1-13
Open Access | Times Cited: 105
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 66
The role of smoking in COVID-19 progression: a comprehensive meta-analysis
Silvano Gallus, Marco Scala, Irene Possenti, et al.
European Respiratory Review (2023) Vol. 32, Iss. 167, pp. 220191-220191
Open Access | Times Cited: 41
Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression
Santenna Chenchula, Kota Vidyasagar, Saman Pathan, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 40
Smoking, SARS-CoV-2 and COVID-19: A review of reviews considering implications for public health policy and practice
Emily J Grundy, Taiba Suddek, Filippos T Filippidis, et al.
Tobacco Induced Diseases (2020) Vol. 18, Iss. July
Open Access | Times Cited: 118
Smoking and COVID-19: What we know so far
Madhur D. Shastri, Shakti D. Shukla, Wai Chin Chong, et al.
Respiratory Medicine (2020) Vol. 176, pp. 106237-106237
Open Access | Times Cited: 108
Prognostic Modeling of COVID-19 Using Artificial Intelligence in the United Kingdom: Model Development and Validation
Ahmed Abdulaal, Aatish Patel, Esmita Charani, et al.
Journal of Medical Internet Research (2020) Vol. 22, Iss. 8, pp. e20259-e20259
Open Access | Times Cited: 82
Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey
Fulvio Adorni, Federica Prinelli, Fabrizio Bianchi, et al.
JMIR Public Health and Surveillance (2020) Vol. 6, Iss. 3, pp. e21866-e21866
Open Access | Times Cited: 81
COVID‐19, smoking, vaping and quitting: a representative population survey in England
Harry Tattan‐Birch, Olga Perski, Sarah E. Jackson, et al.
Addiction (2020) Vol. 116, Iss. 5, pp. 1186-1195
Open Access | Times Cited: 79
Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study
Fabrice Carrat, Xavier de Lamballerie, Delphine Rahib, et al.
International Journal of Epidemiology (2021) Vol. 50, Iss. 5, pp. 1458-1472
Open Access | Times Cited: 79
Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature.
Maria Sofia Cattaruzza, Vincenzo Zagà, Silvano Gallus, et al.
PubMed (2020) Vol. 91, Iss. 2, pp. 106-112
Closed Access | Times Cited: 77
Tobacco Use Changes and Perceived Health Risks among Current Tobacco Users during the COVID-19 Pandemic
Jessica Yingst, Nicolle M. Krebs, Candace Bordner, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 4, pp. 1795-1795
Open Access | Times Cited: 74
Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth
Naomi A van Westen-Lagerweij, Eline Meijer, Elisabeth G. Meeuwsen, et al.
npj Primary Care Respiratory Medicine (2021) Vol. 31, Iss. 1
Open Access | Times Cited: 72
Preliminary impact of the COVID-19 pandemic on smoking and vaping in college students
Alexander W. Sokolovsky, Andrew W. Hertel, Lauren Micalizzi, et al.
Addictive Behaviors (2020) Vol. 115, pp. 106783-106783
Open Access | Times Cited: 70
Page 1 - Next Page

Scroll to top